国产乱人伦中文无无码视频试看 ,成熟人妻换╳╳╳╳,性xxxx18免费观看视频,99香蕉国产精品偷在线观看

技術(shù)文章您現(xiàn)在的位置:首頁 > 技術(shù)文章 > 細(xì)胞庫凍存方案Bambanker無血清即用型細(xì)胞凍存液

細(xì)胞庫凍存方案Bambanker無血清即用型細(xì)胞凍存液

更新時(shí)間:2023-05-27   點(diǎn)擊次數(shù):935次

637521891933579755507.jpg


BAMBANKER產(chǎn)品特點(diǎn)

即用型細(xì)胞凍存液,無需程序性降溫

尤其適用于各類敏感細(xì)胞,如ES細(xì)胞、原代細(xì)胞

高復(fù)蘇率(請見對比圖效果)

可-80℃或液氮中長期凍存,穩(wěn)定保存1年以上

無血清,成份確定,避免由支原體、病毒、朊病毒及其他病毒顆粒引發(fā)的污染

產(chǎn)品經(jīng)無菌檢測,符合日本藥典

產(chǎn)品可2~8 ℃穩(wěn)定保存2年

BAMBANKER操作流程使用說明

收集對數(shù)生長期的細(xì)胞(5 x 105 ~ 1 x 107)

用1ml BambankerTM重懸細(xì)胞,置于凍存管中,無需預(yù)冷。


品名

貨號

規(guī)格

BambankerTM

BB01

120ml





Bambanker系列凍存液

品名

描述

貨號

規(guī)格

BambankerTM Direct

細(xì)胞凍存時(shí)無需離心,非常適用于雜交瘤細(xì)胞

BBD01

20ml

BambankerTM HRM

使用人血清白蛋白,無動物源性

BBH01

20ml





638207828742492274501.jpg


Bambanker使用部分發(fā)表文獻(xiàn)

ü  T. Hikichi et al., Differentiation potential of parthenogenetic embryonic stem cells is improved by nuclear transfer. Stem cells25, 46 (Jan, 2007).

ü  S. Mieno et al., Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells. The Annals of thoracic surgery85, 1361 (Apr, 2008).

ü  S. Hatoya et al., Effect of co-culturing with embryonic fibroblasts on IVM, IVF and IVC of canine oocytes. Theriogenology66, 1083 (Sep 15, 2006).

ü  D. Liu et al., Relation between human decay-accelerating factor (hDAF) expression in pig cells andinhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation. Xenotransplantation14, 67 (Jan, 2007).

ü  S. K. Zaidi et al., Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proceedings of the National Academy of Sciences of the United States of America104, 19861 (Dec 11, 2007).

ü  S. Mieno et al., Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells. Journal of cardiac surgery25, 618 (Sep, 2010).

ü  Y. Shimizu et al., Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages. Cancer science100, 481 (Mar, 2009).


靶點(diǎn)科技(北京)有限公司

靶點(diǎn)科技(北京)有限公司

地址:中關(guān)村生命科學(xué)園北清創(chuàng)意園2-4樓2層

© 2024 版權(quán)所有:靶點(diǎn)科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:263039  站點(diǎn)地圖  技術(shù)支持:化工儀器網(wǎng)  管理登陸